Correction: Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression (Oncogenesis, (2018), 7, 5, (41), 10.1038/s41389-018-0049-3);Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression

Oncogenesis

Volumn 7, Issue 5, 2018, Pages

  Wang, Furong ^a   Li, Bin ^a   Wei, Yucai ^a   Zhao, Yang ^a   Wang, Li ^a   Zhang, Peng ^a   Yang, Jinwei ^a   He, Wenting ^a   Chen, Hao ^a   Jiao, Zuoyi ^a   Li, Yumin ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CD206 ANTIGEN; CD64 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXOSOME; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 85047624024     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/s41389-022-00381-y     Document Type: Erratum

References (33)

1. Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87-108 (2015).
2. Plummer, M., Franceschi, S., Vignat, J., Forman, D. &de Martel, C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J. Cancer 136, 487-490 (2015).
3. Qian, B. Z. &Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010).
4. Toh, B., Toh, B., Abastado, J. P. &Abastado, J. P. Myeloid cells: prime drivers of tumor progression. Oncoimmunology 1, 1360-1367 (2012).
5. Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78 (2004).
6. Lewis, C. E., Harney, A. S. &Pollard, J. W. The multifaceted role of perivascular macrophages in tumors. Cancer Cell 30, 18-25 (2016).
7. Chen, X. W. et al. CYP4A in tumor-associated macrophages promotes premetastatic niche formation and metastasis. Oncogene 36, 5045 (2017).
8. Riabov, V. et al. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front. Physiol. 5, 75 (2014).
9. Wang, B. et al. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann. Surg. Oncol. 18, 2585-2593 (2011).
10. Quatromoni, J. G. &Eruslanov, E. Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am. J. Transl. Res. 4, 376-389 (2012).
11. Bardhan, K., Anagnostou, T. &Boussiotis, V. A. The PD1:PD-L1/2 pathway from discovery to clinical implementation. Front. Immunol. 7, 550 (2016).
12. Huang, X. et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl Acad. Sci. USA 106, 6303-6308 (2009).
13. Chen, W., Wang, J., Jia, L., Liu, J. &Tian, Y. Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan. Cell Death Dis. 7, e2115 (2016).
14. Bally, A. P. et al. NF-kappaB regulates PD-1 expression in macrophages. J. Immunol. 194, 4545-4554 (2015).
15. Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495-499 (2017).
16. Peinado, H., Lavotshkin, S. &Lyden, D. The secreted factors responsible for premetastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21, 139-146 (2011).
17. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
18. Ratajczak, J. et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20, 847-856 (2006).
19. Wang, W. et al. Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget 8, 43180-43191 (2017).
20. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
21. Dickman, C. T. et al. Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes. Oncotarget 8, 15252-15266 (2017).
22. Melo, S. A. et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26, 707-721 (2014).
23. Suetsugu, A. et al. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv. Drug Deliv. Rev. 65, 383-390 (2013).
24. Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329-335 (2015).
25. Monzo, M. et al. Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer. Oncotarget 8, 30859-30869 (2017).
26. Sica, A., Schioppa, T., Mantovani, A. &Allavena, P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727 (2006).
27. Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70, 5728-5739 (2010).
28. Chen, Z. et al. Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages. Oncotarget 7, 67387-67402 (2016).
29. Ying, X. et al. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages. Oncotarget 7, 43076-43087 (2016).
30. Yamada, N. et al. Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-beta1-mediated suppression. Oncotarget 7, 27033-27043 (2016).
31. Ding, G. et al. Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget 6, 29877-29888 (2015).
32. Cobb, D. A., KIM, O. K., Golden-Mason, L., Rosen, H. R., &Hahn, Y. S. Hepatocytederived exosomes promote T follicular regulatory cell expansion during HCV infection. Hepatology 67, 71-85 (2018).
33. Maybruck, B. T., Pfannenstiel, L. W., Diaz-Montero, M. &Gastman, B. R. Tumorderived exosomes induce CD8+ T cell suppressors. J. Immunother. Cancer 5, 65 (2017).